REGN
REGENERON PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$930.67
−4.39%Forward multiples
Based on analyst estimates
- P/E forward
- 11.64x
- P/E 2026E
- 14.36x
- P/E 2027E
- 13.68x
- P/E 2028E
- 12.35x
- P/S forward
- 4.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.82x
- PEG TTM
- 0.29x
- Price / book
- 2.87x
- Price / sales
- 5.70x
- Price / cash flow
- 20.90x
Enterprise value
- Enterprise value
- $89.7B
- EV / sales
- 5.31x
- EV / EBITDA
- 14.36x
- EV / EBIT
- 17.97x
- Market cap
- $96.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026